WWD stock is up 85% in a year, driven by aerospace and industrial demand, strong 2026 guidance, major investments and aggressive shareholder returns.

Investors need to pay close attention to Shift4 Payments stock based on the movements in the options market lately.

Live demos in Las Vegas will highlight DrivebuddyAI's vision-first, continuous-learning AI platform trained on billions of kilometers of real-world driving data and uniquely positioned as the only driver monitoring system validated under both Indian AIS-184 and EU GSR 2144 standards. Live demos in Las Vegas will highlight DrivebuddyAI's vision-first, continuous-learning AI platform trained on billions of kilometers of real-world driving data and uniquely positioned as the only driver monitoring system validated under both Indian AIS-184 and EU GSR 2144 standards.

Allstate Corporation (ALL) remains a Buy, with strong business performance and sharply rising 2025 EPS estimates despite recent stock underperformance versus the S&P 500. ALL's valuation has become highly attractive, with the stock trading at 7.1x 2025 EPS and at a substantial discount to peers, offering better downside protection. Recent capital allocation moves include an 8.7% dividend increase and a new $1.5 billion share repurchase program.

NEW YORK--(BUSINESS WIRE)--Klarna, the global digital bank and flexible payments provider, today reports an increase in U.S. holiday spending beyond traditional retail, with consumers driving triple-digit year-over-year growth across entertainment (+130%), experiences (+115%) and automotive products (100%), such as vehicle maintenance and repairs, from December 1 through Monday, December 22, signaling a clear shift toward experiential and high-value practical purchases this season. The results.

ABM Industries remains a buy, with strong organic and acquisition-driven growth despite recent share underperformance. ABM's Technical Solutions and Aviation segments delivered standout revenue and operating income growth, offsetting mixed results elsewhere. Management is prioritizing customer retention and expansion, executing strategic acquisitions, and launching a $35 million cost-cutting program for 2026.

Sprott Active Gold & Silver Miners ETF has delivered 125% returns since inception, significantly outperforming the S&P 500 and VOO. GBUG's active management, precious metals focus, and geographic diversification position it well amid ongoing macroeconomic uncertainty and safe-haven demand. The ETF's 0.89% expense ratio and concentrated 36-holding portfolio offer competitive cost structure and potential for outperformance.

LOS ANGELES, Dec. 23, 2025 (GLOBE NEWSWIRE) -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Skye Bioscience, Inc. (“Skye” or “the Company”) (NASDAQ: SKYE) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between November 4, 2024 and October 3, 2025, inclusive (the “Class Period”), are encouraged to contact the firm before January 16, 2026.

Lead Partner Reed Kathrein: Scrutiny Focuses on Extent of Leadership Awareness Regarding Chronic Payor Denials and Collectability Issues SAN FRANCISCO , Dec. 23, 2025 /PRNewswire/ -- Prominent shareholder rights law firm Hagens Berman has opened an investigation into potential securities law violations by Ardent Health, Inc. (NYSE: ARDT) following the company's recent Q3 2025 financial disclosures. The disclosures revealed significant adverse accounting adjustments totaling $97 million that sent the stock tumbling over 33%.

RZLT Investors with Losses Encouraged to Contact the Firm SAN FRANCISCO , Dec. 23, 2025 /PRNewswire/ -- On December 11, 2025, investors in Rezolute, Inc. (NASDAQ: RZLT) saw the price of their shares crater as much as 90% during intraday trading after the company revealed the failure of its Phase 3 sunRIZE trial for ersodetug ("erso"). The company has billed this drug as a potential treatment for hypoglycemia caused by hyperinsulinism ("HI").

Vancouver, BC – December 23, 2025 – TheNewswire - Global Stocks News - Sponsored content disseminated on behalf of Dolly Varden Silver. On December 23, 2025 Dolly Varden Silver (TSX-V: DV) (NYSE MKT: DVS) (FSE: DVQ) CEO Shawn Khunkhun sent a year-end letter to shareholders. 2025 Represented a Step Change for Dolly Varden Silver

WESTLAKE, Texas--(BUSINESS WIRE)--The Charles Schwab Corporation (Schwab) today announced it will match the U.S. government's one-time $1,000 contribution to eligible newborn children of Schwab's U.S. employees, providing an additional $1,000 per eligible child. The children's saving account program, known as “Trump Accounts,” was signed into law by President Trump and provides a $1,000 pilot contribution from the U.S. Treasury into a tax-advantaged account for eligible children born in the U.S.

SAN FRANCISCO--(BUSINESS WIRE)--On December 12, 2025, investors in Fermi Inc. (NASDAQ: FRMI) saw the price of their shares crater about 33% after the company revealed that a prospective anchor tenant (“First Tenant”) for Fermi's Project Matador (the company's Advanced Energy and Intelligence Campus at Texas Tech University) terminated an agreement that would have advanced $150 million to help fund construction. The company has billed Matador as a multi-gigawatt energy and data center developmen.

SAN FRANCISCO--(BUSINESS WIRE)--A securities class action lawsuit styled Smith v. F5, Inc., et al., No. 2:25-cv-02619 (W.D. Wash.) has been filed, seeking to represent investors in F5 (NASDAQ: FFIV) who purchased or otherwise acquired F5 securities between October 28, 2024 and October 27, 2025. The lawsuit comes in the wake of F5's October 15, 2025 report that, on August 9, 2025, it learned of a major cybersecurity incident involving a nation-state actor that gained unauthorized access to certa.

Total revenues decreased by 1 5 . 0 % year over year to RMB303.6 million (US$4 2.

Partner Reed Kathrein Investigating Whether Management Misrepresented Provision Trends and Lending Risk SAN FRANCISCO , Dec. 23, 2025 /PRNewswire/ -- National shareholder rights law firm Hagens Berman has launched an investigation into potential securities law violations by Klarna Group plc (NYSE: KLAR) following the company's recent Q3 2025 financial results. The disappointing results revealed a staggering increase in the provision for credit losses.

DehydraTECH-semaglutide reduced overall side effects by 48% as compared to Rybelsus® DehydraTECH-semaglutide reduced gastrointestinal side effects by 55% as compared to Rybelsus® Recent financings create runway for prospective new 2026 development opportunities KELOWNA, BC / ACCESS Newswire / December 23, 2025 / Lexaria Bioscience Corp. (Nasdaq:LEXX)(Nasdaq:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, provides the following final primary and major secondary efficacy endpoint results update on its Phase 1b, 12-week chronic study GLP-1-H24-4 (the " Study " or the " Lexaria Study "), recently completed in Australia, focusing on 4 DehydraTECH ® ( "DHT" ) study …

DehydraTECH-semaglutide reduced overall side effects by 48% as compared to Rybelsus DehydraTECH-semaglutide reduced gastrointestinal side effects by 55% as compared to Rybelsus

MGM China extends the right to use "MGM" name through the 2032 Concession term with an automatic extension if a further Concession is granted or awarded LAS VEGAS , Dec. 23, 2025 /PRNewswire/ -- MGM Resorts International (NYSE: MGM) ("MGM Resorts" or the "Company") has entered into a new Long Term Branding Agreement with MGM China Holdings Limited ("MGM China"), effective January 1, 2026 ("Branding Agreement"). The Branding Agreement provides for a term through the end of the current concession in 2032.

Crexendo (CXDO) delivered double-digit revenue growth and expanding margins in Q3 2025, with EPS up 67% which drove the stock to outperform the S&P 500. CXDO's AI-driven product roadmap, including the upcoming Kairo receptionist orchestrator, targets SMB efficiency and higher average revenue per account. Valuation remains attractive at 19.3x 2026E EPS and a PEG of 1.02, supporting strong upside as CXDO sustains double-digit growth and margin expansion.